microRNA‑181 promotes prostate cancer cell proliferation by regulating DAX‑1 expression

Tong,Shi‑Jun; Liu,Jun; Wang,Xiang; Qu,Lian‑Xi

doi:10.3892/etm.2014.1846

microRNA‑181 promotes prostate cancer cell proliferation by regulating DAX‑1 expression

Authors:
- Shi‑Jun Tong
- Jun Liu
- Xiang Wang
- Lian‑Xi Qu
View Affiliations

Affiliations: Department of Urologic Surgery, Huashan Hospital Affiliated to Fudan University, Shanghai 200040, P.R. China
Published online on: July 16, 2014 https://doi.org/10.3892/etm.2014.1846
Pages: 1296-1300

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

microRNAs (miRNAs) are a class of short noncoding RNA molecules that have a critical role in the initiation and progression of types of human cancer, including prostate cancer. In the present study, the expression of miR‑181 in prostate cancer tissues was evaluated and was demonstrated to be significantly upregulated in prostate cancer tissues compared with that in adjacent normal tissues. The results of in vitro MTT and BrdU incorporation assays, as well as cell‑cycle analysis, indicated that miR‑181 overexpression markedly promoted the proliferation of LNCaP cells. Furthermore, miR‑181 overexpression was found to promote the progression of LNCaP tumor growth in nude mice. Mechanistic studies demonstrated that dosage‑sensitive sex reversal, adrenal hypoplasia critical region, on chromosome X, gene 1 (DAX‑1), a negative regulator of androgen receptor in prostate cancer, was inhibited by miR‑181 overexpression. Therefore, the results from the present study suggest that miR‑181 functions as a growth‑suppressive miRNA during prostate cancer development.

View Figures

View References

1	Emery JD, Shaw K, Williams B, et al: The role of primary care in early detection and follow-up of cancer. Nat Rev Clin Oncol. 11:38–48. 2014. View Article : Google Scholar : PubMed/NCBI
2	Hutchinson L: Genetics: tracking clonal origin of prostate cancer. Nat Rev Clin Oncol. 11:42014. View Article : Google Scholar
3	Ling H, Fabbri M and Calin GA: MicroRNAs and other non-coding RNAs as targets for anticancer drug development. Nat Rev Drug Discov. 12:847–865. 2013. View Article : Google Scholar : PubMed/NCBI
4	van Kouwenhove M, Kedde M and Agami R: MicroRNA regulation by RNA-binding proteins and its implications for cancer. Nat Rev Cancer. 11:644–656. 2011.PubMed/NCBI
5	Sun K and Lai EC: Adult-specific functions of animal microRNAs. Nat Rev Genet. 14:535–548. 2013. View Article : Google Scholar : PubMed/NCBI
6	Lewis H, Lance R, Troyer D, et al: miR-888 is an expressed prostatic secretions-derived microRNA that promotes prostate cell growth and migration. Cell Cycle. 13:227–239. 2014. View Article : Google Scholar : PubMed/NCBI
7	Ji J, Yamashita T, Budhu A, et al: Identification of microRNA-181 by genome-wide screening as a critical player in EpCAM-positive hepatic cancer stem cells. Hepatology. 50:472–480. 2009. View Article : Google Scholar : PubMed/NCBI
8	Wang B, Hsu SH, Majumder S, et al: TGFbeta-mediated upregulation of hepatic miR-181b promotes hepatocarcinogenesis by targeting TIMP3. Oncogene. 29:1787–1797. 2010. View Article : Google Scholar : PubMed/NCBI
9	Lin S, Pan L, Guo S, et al: Prognostic role of microRNA-181a/b in hematological malignancies: a meta-analysis. PLoS One. 8:e595322013. View Article : Google Scholar : PubMed/NCBI
10	Holter E, Kotaja N, Mäkela S, et al: Inhibition of androgen receptor (AR) function by the reproductive orphan nuclear receptor DAX-1. Mol Endocrinol. 16:515–528. 2002. View Article : Google Scholar : PubMed/NCBI
11	Hessels D and Schalken JA: Urinary biomarkers for prostate cancer: a review. Asian J Androl. 15:333–339. 2013. View Article : Google Scholar : PubMed/NCBI
12	Sita-Lumsden A, Dart DA, Waxman J and Bevan CL: Circulating microRNAs as potential new biomarkers for prostate cancer. Br J Cancer. 108:1925–1930. 2013. View Article : Google Scholar : PubMed/NCBI
13	Kim WT and Kim WJ: MicroRNAs in prostate cancer. Prostate Int. 1:3–9. 2013. View Article : Google Scholar
14	McCabe ER: DAX1: Increasing complexity in the roles of this novel nuclear receptor. Mol Cell Endocrinol. 265–266:179–182. 2007.PubMed/NCBI
15	El-Khairi R, Martinez-Aguayo A, Ferraz-de-Souza B, Lin L and Achermann JC: Role of DAX-1 (NR0B1) and steroidogenic factor-1 (NR5A1) in human adrenal function. Endocr Dev. 20:38–46. 2011.PubMed/NCBI
16	Li J, Lu Y, Liu R, et al: DAX1 suppresses FXR transactivity as a novel co-repressor. Biochem Biophys Res Commun. 412:660–666. 2011. View Article : Google Scholar : PubMed/NCBI
17	Jadhav U, Harris RM and Jameson JL: Hypogonadotropic hypogonadism in subjects with DAX1 mutations. Mol Cell Endocrinol. 346:65–73. 2011. View Article : Google Scholar : PubMed/NCBI
18	Chae BJ, Lee A, Bae JS, Song BJ and Jung SS: Expression of nuclear receptor DAX-1 and androgen receptor in human breast cancer. J Surg Oncol. 103:768–772. 2011. View Article : Google Scholar : PubMed/NCBI
19	Lanzino M, Maris P, Sirianni R, et al: DAX-1, as an androgen-target gene, inhibits aromatase expression: a novel mechanism blocking estrogen-dependent breast cancer cell proliferation. Cell Death Dis. 4:e7242013. View Article : Google Scholar : PubMed/NCBI
20	Lalli E and Alonso J: Targeting DAX-1 in embryonic stem cells and cancer. Expert Opin Ther Targets. 14:169–177. 2010. View Article : Google Scholar : PubMed/NCBI